INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 265 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,553,168 | -64.8% | 29,817 | -57.2% | 0.04% | -63.1% |
| Q2 2023 | $4,415,557 | -24.7% | 69,734 | -35.6% | 0.10% | -40.5% |
| Q1 2023 | $5,867,369 | -64.1% | 108,354 | -64.9% | 0.17% | -62.5% |
| Q4 2022 | $16,333,546 | +8.5% | 308,646 | -4.6% | 0.46% | +4.1% |
| Q3 2022 | $15,058,000 | +4.1% | 323,609 | +27.7% | 0.44% | +9.4% |
| Q2 2022 | $14,459,000 | -2.1% | 253,319 | +5.0% | 0.40% | +16.0% |
| Q1 2022 | $14,762,000 | +37.7% | 241,255 | +17.8% | 0.35% | +54.4% |
| Q4 2021 | $10,720,000 | +192.3% | 204,822 | +108.2% | 0.23% | +175.6% |
| Q3 2021 | $3,667,000 | – | 98,356 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |